Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights: Revenue ...

Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...

Insulet Corporation: Insulet Accelerates Global Growth with Launch of Omnipod 5 and Omnipod Discover in Spain, Expanding Access to Tubeless Diabetes Technology

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...
Zacks.com on MSN

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...
Le Lézard

Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discovertm in Spain, Expanding Access to Tubeless Diabetes Technology

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the commercial launch of its Omnipod 5 ...
Le Lézard

San Diego's Largest Community-Powered Cancer Research Fundraiser Returns: Curebound Cancer Challenge to Accelerate Cures

On Saturday, August 1, San Diego will come together for a day of movement, community and hope at the Curebound Cancer Challenge, San Diego County's largest community-driven fundraiser for cancer ...